Literature DB >> 28602627

Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.

Dan Chen1, Satoko Ito1, Toshinori Hyodo1, Eri Asano-Inami2, Hong Yuan3, Takeshi Senga4.   

Abstract

DEPDC1 (DEP domain containing 1) is overexpressed in multiple cancers and is associated with cell cycle progression. In this report, we have investigated the expression, localization, phosphorylation and function of DEPDC1 during mitosis. DEPDC1 has two isoforms (isoform a and isoform b), and both of them are increased in mitosis and degraded once cells exit mitosis. DEPDC1a is localized to the centrosome in metaphase, whereas DEPDC1b is localized to the entire cell cortex during mitosis. DEPDC1a, but not DEPDC1b, was required for the integrity of centrosome and organization of the bipolar spindle. Mass spectrometry and biochemical analyses revealed phosphorylation of DEPDC1 at Ser110. The phosphorylation of Ser110 is essential for localization of DEPDC1a to the centrosome. Consistently, non-phosphorylation mutants of DEPDC1a did not rescue disruption of centrosome organization by depletion of endogenous DEPDC1. Our results show a novel role for DEPDC1 in maintaining centrosome integrity during mitosis for the accurate distribution of chromosomes.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  CDK1; Centrosome; DEPDC1; Mitosis; Phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28602627     DOI: 10.1016/j.yexcr.2017.06.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  An E2-ubiquitin thioester-driven approach to identify substrates modified with ubiquitin and ubiquitin-like molecules.

Authors:  Gábor Bakos; Lu Yu; Igor A Gak; Theodoros I Roumeliotis; Dimitris Liakopoulos; Jyoti S Choudhary; Jörg Mansfeld
Journal:  Nat Commun       Date:  2018-11-14       Impact factor: 14.919

2.  Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.

Authors:  Ilaria Lorenzon; Ilenia Pellarin; Ilenia Pellizzari; Sara D'Andrea; Barbara Belletti; Maura Sonego; Gustavo Baldassarre; Monica Schiappacassi
Journal:  Cells       Date:  2019-12-21       Impact factor: 6.600

3.  High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma.

Authors:  Pulin Li; Xiaojuan Chen; Sijing Zhou; Xingyuan Xia; Enze Wang; Rui Han; Daxiong Zeng; Guanghe Fei; Ran Wang
Journal:  J Inflamm Res       Date:  2022-07-23

4.  STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.

Authors:  Changmin Liu; Xiaoming Li; Yanzhang Hao; Feng Wang; Zhiwen Cheng; Haitao Geng; Dianzhong Geng
Journal:  Aging (Albany NY)       Date:  2020-05-12       Impact factor: 5.682

5.  Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability.

Authors:  Anqi Jing; Frederick S Vizeacoumar; Sreejit Parameswaran; Bjorn Haave; Chelsea E Cunningham; Yuliang Wu; Roland Arnold; Keith Bonham; Andrew Freywald; Jie Han; Franco J Vizeacoumar
Journal:  NPJ Syst Biol Appl       Date:  2018-10-24

6.  Establishment of rat anti-canine DEP domain containing 1B (DEPDC1B) monoclonal antibodies.

Authors:  Masaya Igase; Yuki Morinaga; Masahiro Kato; Toshihiro Tsukui; Yusuke Sakai; Masaru Okuda; Takuya Mizuno
Journal:  J Vet Med Sci       Date:  2020-03-06       Impact factor: 1.267

7.  Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1.

Authors:  Xiao-Wei Dang; Qi Pan; Zhen-Hai Lin; Hao-Hao Wang; Lu-Hao Li; Lin Li; Dong-Qi Shen; Pei-Ju Wang
Journal:  Aging (Albany NY)       Date:  2021-05-25       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.